Clinical trial update: International Breast Cancer Study Group

Karen N. Price; Aron Goldhirsch

doi:10.1186/bcr1334

Clinical trial update: International Breast Cancer Study Group

Karen N. Price, Aron Goldhirsch

Istituto Europeo di Oncologia

Research output: Contribution to journal › Article › peer-review

Abstract

The International Breast Cancer Study Group (IBCSG) has been conducting large, phase III clinical trials since 1978. Prior to 1986, these activities were carried out under the name of Ludwig Breast Cancer Study Group. Seven trials of adjuvant therapies are currently open for patient accrual, five of which are described in this report. The IBCSG has been a leader in the field of tailored treatment approaches for specific subpopulations of patients with breast cancer, believing that what is best for the majority may not be best for a defined minority.

Original language	English
Pages (from-to)	252-254
Number of pages	3
Journal	Breast Cancer Research
Volume	7
Issue number	6
DOIs	https://doi.org/10.1186/bcr1334
Publication status	Published - Dec 2005

ASJC Scopus subject areas

Cancer Research
Oncology

Access to Document

10.1186/bcr1334

Fingerprint Dive into the research topics of 'Clinical trial update: International Breast Cancer Study Group'. Together they form a unique fingerprint.

Cite this

@article{42b7952040a54afd93b871a2d8fb1173,

title = "Clinical trial update: International Breast Cancer Study Group",

abstract = "The International Breast Cancer Study Group (IBCSG) has been conducting large, phase III clinical trials since 1978. Prior to 1986, these activities were carried out under the name of Ludwig Breast Cancer Study Group. Seven trials of adjuvant therapies are currently open for patient accrual, five of which are described in this report. The IBCSG has been a leader in the field of tailored treatment approaches for specific subpopulations of patients with breast cancer, believing that what is best for the majority may not be best for a defined minority.",

author = "Price, {Karen N.} and Aron Goldhirsch",

year = "2005",

month = dec,

doi = "10.1186/bcr1334",

language = "English",

volume = "7",

pages = "252--254",

journal = "Breast Cancer Research",

issn = "1465-5411",

publisher = "BioMed Central",

number = "6",

}

TY - JOUR

T1 - Clinical trial update

T2 - International Breast Cancer Study Group

AU - Price, Karen N.

AU - Goldhirsch, Aron

PY - 2005/12

Y1 - 2005/12

N2 - The International Breast Cancer Study Group (IBCSG) has been conducting large, phase III clinical trials since 1978. Prior to 1986, these activities were carried out under the name of Ludwig Breast Cancer Study Group. Seven trials of adjuvant therapies are currently open for patient accrual, five of which are described in this report. The IBCSG has been a leader in the field of tailored treatment approaches for specific subpopulations of patients with breast cancer, believing that what is best for the majority may not be best for a defined minority.

AB - The International Breast Cancer Study Group (IBCSG) has been conducting large, phase III clinical trials since 1978. Prior to 1986, these activities were carried out under the name of Ludwig Breast Cancer Study Group. Seven trials of adjuvant therapies are currently open for patient accrual, five of which are described in this report. The IBCSG has been a leader in the field of tailored treatment approaches for specific subpopulations of patients with breast cancer, believing that what is best for the majority may not be best for a defined minority.

UR - http://www.scopus.com/inward/record.url?scp=29244440841&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=29244440841&partnerID=8YFLogxK

U2 - 10.1186/bcr1334

DO - 10.1186/bcr1334

M3 - Article

C2 - 16280051

AN - SCOPUS:29244440841

VL - 7

SP - 252

EP - 254

JO - Breast Cancer Research

JF - Breast Cancer Research

SN - 1465-5411

IS - 6

ER -